UniProt ID | MYLIP_HUMAN | |
---|---|---|
UniProt AC | Q8WY64 | |
Protein Name | E3 ubiquitin-protein ligase MYLIP | |
Gene Name | MYLIP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 445 | |
Subcellular Localization |
Cytoplasm . Cell membrane Peripheral membrane protein . |
|
Protein Description | E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.. | |
Protein Sequence | MLCYVTRPDAVLMEVEVEAKANGEDCLNQVCRRLGIIEVDYFGLQFTGSKGESLWLNLRNRISQQMDGLAPYRLKLRVKFFVEPHLILQEQTRHIFFLHIKEALLAGHLLCSPEQAVELSALLAQTKFGDYNQNTAKYNYEELCAKELSSATLNSIVAKHKELEGTSQASAEYQVLQIVSAMENYGIEWHSVRDSEGQKLLIGVGPEGISICKDDFSPINRIAYPVVQMATQSGKNVYLTVTKESGNSIVLLFKMISTRAASGLYRAITETHAFYRCDTVTSAVMMQYSRDLKGHLASLFLNENINLGKKYVFDIKRTSKEVYDHARRALYNAGVVDLVSRNNQSPSHSPLKSSESSMNCSSCEGLSCQQTRVLQEKLRKLKEAMLCMVCCEEEINSTFCPCGHTVCCESCAAQLQSCPVCRSRVEHVQHVYLPTHTSLLNLTVI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MLCYVTRPDAV ----CCEEEECCCEE | 10.82 | 23663014 | |
6 | Phosphorylation | --MLCYVTRPDAVLM --CCEEEECCCEEEE | 15.26 | 23663014 | |
47 | Phosphorylation | DYFGLQFTGSKGESL EEEEEEEECCCCCEE | 27.82 | - | |
49 | Phosphorylation | FGLQFTGSKGESLWL EEEEEECCCCCEEHH | 34.14 | - | |
137 | Ubiquitination | DYNQNTAKYNYEELC CCCCCHHCCCHHHHH | 31.80 | - | |
146 | Ubiquitination | NYEELCAKELSSATL CHHHHHHHHHHHHHH | 59.18 | - | |
149 | Phosphorylation | ELCAKELSSATLNSI HHHHHHHHHHHHHHH | 21.01 | 25159151 | |
150 | Phosphorylation | LCAKELSSATLNSIV HHHHHHHHHHHHHHH | 37.59 | 26074081 | |
152 | Phosphorylation | AKELSSATLNSIVAK HHHHHHHHHHHHHHH | 28.55 | 26074081 | |
159 | Ubiquitination | TLNSIVAKHKELEGT HHHHHHHHHHHHCCC | 44.29 | - | |
257 | Phosphorylation | VLLFKMISTRAASGL EEEEEHHHHHHHHHH | 14.35 | 22210691 | |
258 | Phosphorylation | LLFKMISTRAASGLY EEEEHHHHHHHHHHH | 17.25 | 22210691 | |
269 | Phosphorylation | SGLYRAITETHAFYR HHHHHHHHHCCCCCC | 33.57 | 30576142 | |
279 | Phosphorylation | HAFYRCDTVTSAVMM CCCCCCCHHHHHHHH | 29.34 | 29759185 | |
281 | Phosphorylation | FYRCDTVTSAVMMQY CCCCCHHHHHHHHHH | 17.04 | 29759185 | |
282 | Phosphorylation | YRCDTVTSAVMMQYS CCCCHHHHHHHHHHC | 17.96 | 30576142 | |
318 | Phosphorylation | YVFDIKRTSKEVYDH EEEEEECCCHHHHHH | 38.87 | - | |
319 | Phosphorylation | VFDIKRTSKEVYDHA EEEEECCCHHHHHHH | 30.74 | - | |
323 | Phosphorylation | KRTSKEVYDHARRAL ECCCHHHHHHHHHHH | 11.78 | - | |
377 | Ubiquitination | QTRVLQEKLRKLKEA HHHHHHHHHHHHHHH | 40.40 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MYLIP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MYLIP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CNPY2_HUMAN | CNPY2 | physical | 12826659 | |
MYLIP_HUMAN | MYLIP | physical | 12826659 | |
LDLR_HUMAN | LDLR | physical | 21734303 | |
MYLIP_HUMAN | MYLIP | physical | 21685362 | |
LDLR_HUMAN | LDLR | physical | 21685362 | |
UB2D1_HUMAN | UBE2D1 | physical | 21685362 | |
LDLR_HUMAN | LDLR | physical | 22109552 | |
VLDLR_HUMAN | VLDLR | physical | 22109552 | |
LRP8_HUMAN | LRP8 | physical | 22109552 | |
ML12B_HUMAN | MYL12B | physical | 10593918 | |
UB2D2_HUMAN | UBE2D2 | physical | 21685362 | |
UB2D3_HUMAN | UBE2D3 | physical | 21685362 | |
UB2D4_HUMAN | UBE2D4 | physical | 21685362 | |
UB2D1_HUMAN | UBE2D1 | physical | 21734303 | |
UBE2N_HUMAN | UBE2N | physical | 21734303 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
T22D4_HUMAN | TSC22D4 | physical | 25416956 | |
RASF5_HUMAN | RASSF5 | physical | 25416956 | |
MIPO1_HUMAN | MIPOL1 | physical | 25416956 | |
LDLR_HUMAN | LDLR | physical | 23382078 | |
CTR9_HUMAN | CTR9 | physical | 28514442 | |
WDFY1_HUMAN | WDFY1 | physical | 28514442 | |
MYCB2_HUMAN | MYCBP2 | physical | 28514442 | |
PAF1_HUMAN | PAF1 | physical | 28514442 | |
UBA6_HUMAN | UBA6 | physical | 28514442 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...